Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Enterprise Therapeutics Limited
Sponsor

Enterprise Therapeutics Limited

United Kingdom Science Park Square, Falmer, BN1 9SB, United Kingdom

About the sponsor

Enterprise Therapeutics Limited focuses its clinical research on cystic fibrosis, with interest in treatments designed for people living with this inherited respiratory disease. The funded work centers on inhaled therapies intended to address lung function and disease-related symptoms in pwCF.

  • Cystic Fibrosis
  • Respiratory Disease
  • Inherited Disease

The sponsor’s clinical activity includes evaluation of inhaled therapeutic approaches aimed at improving pulmonary function, with attention to measures such as forced expiratory volume in 1 second and other markers relevant to airway health.

About Specializations

Enterprise Therapeutics Limited runs clinical trials in conditions such as Cystic fibrosis, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Cystic fibrosis

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:3-Amino-N-{[5-[4-[Bis[(2S,3R,4R,5R)-2,3,4,5,6-Pentahydroxyhexyl]Amino]Piperidine-1-Carbonyl]-1,3-Diethyl-Benzimidazol-1-Ium-2-Yl]Methyl}-5H-Pyrrolo[2,3-B]Pyrazine-2-Carboxamide Dihydrochloride Chloride
  • Sponsor:Enterprise Therapeutics Limited

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.